Develop Archives - Mediarabe

U.S. signs agreement with AstraZeneca to develop, supply COVID-19 antibody treatment

October 10, 2020

(Reuters) – The U.S. government on Friday signed an agreement with AstraZeneca Plc <AZN.L> worth $486 million to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment, a similar class of drugs that was used to treat President Donald Trump.

The U.S. health agency will provide the funding to AstraZeneca for two Phase 3 clinical trials under operation Warp Speed, which is aimed at speeding up treatments and vaccines for COVID-19.

One trial will evaluate the safety and efficacy of the experimental treatment to prevent infection for up to 12 months, in about 5,000 participants, while the second trial will evaluate post-exposure preventative and pre-emptive treatment in roughly 1,100 participants.

AstraZeneca said it plans to supply up to 100,000 doses starting towards the end of 2020 and the US Government can acquire up to an additional one million doses in 2021 under a separate agreement.

In

U.S. Signs Agreement With AstraZeneca to Develop, Supply COVID-19 Antibody Treatment | Top News

October 10, 2020

| No Comments

| Health

(Reuters) – The U.S. government on Friday signed an agreement with AstraZeneca Plc

worth $486 million to develop and secure supplies of up to 100,000 doses of COVID-19 antibody treatment, a similar class of drugs that was used to treat President Donald Trump.

The U.S. health agency will provide the funding to AstraZeneca for two Phase 3 clinical trials under operation Warp Speed, which is aimed at speeding up treatments and vaccines for COVID-19.

One trial will evaluate the safety and efficacy of the experimental treatment to prevent infection for up to 12 months, in about 5,000 participants, while the second trial will evaluate post-exposure preventative and pre-emptive treatment in roughly 1,100 participants.

AstraZeneca said it plans to supply up to 100,000 doses starting towards the end of 2020 and the US Government can acquire up to an additional one million doses in 2021 under a separate agreement.

In a

NEC OncoImmunity AS and Oslo University Hospital Team Up to Develop a Diagnostic for COVID-19 Using Artificial Intelligence

October 8, 2020

| No Comments

| Health News

NEC OncoImmunity AS (NOI), a subsidiary of NEC Corporation (NEC), and Oslo University Hospital (OUH) are pleased to announce that they have recently been awarded a prestigious grant from the Research Council of Norway (RCN) to develop an artificial intelligence (AI) platform that will enable the rapid design of T-cell diagnostics for emerging or endemic infectious diseases. The project will develop a novel T-cell diagnostic for the current COVID-19 pandemic to complement the current serological tests. This will improve the ability to identify immune responses and acquired immunity, which is desperately needed to deal with the COVID-19 crisis.

Current technologies involve extensive trial and error to define exactly which parts of the pathogen induces robust immunity. These so-called immunodominant epitopes need to be identified for the general population. These demanding, work-intensive and time-consuming steps are necessary to develop tests to monitor the T-cell response to viruses such as SARS-CoV-2 (the

New Study Shows That Playing With Dolls Allows Children to Develop Empathy and Social Processing Skills

October 1, 2020

| No Comments

| Health Article

Barbie® and neuroscientists from Cardiff University have collaborated on a new study which for the first time uses neuroimaging as evidence to explore the effects of doll play

Evidence shows that doll play activates brain regions which are associated with social information processing and empathy, indicating that doll play enables children to rehearse, use and perform these skills even when playing on their own

To understand the relevancy of the study, Barbie independently commissioned a global survey in 22 different countries questioning 15,000 parents which showed 91 percent of parents rank empathy as a key social skill they would like their child to develop, but only 26 percent were aware that doll play could help their child develop these skills

Today Barbie launches an online hub featuring resources for parents, caregivers, and children, to support them in their social processing skills which has been developed alongside leading empathy expert, writer,

O2 Industries and Georges St-Pierre Partner to Develop First-of-its-Kind Fitness Respirator

September 29, 2020

| No Comments

| Health And Fitness

O2 Industries (the Company), a leading manufacturer of reusable respirators since 2014, today announces its partnership with former Ultimate Fighting Championship (UFC) fighter Georges St-Pierre, to develop a fitness respirator. The partnership news follows the Company’s recent announcement that it has been selected as the official respirator partner of the UFC.

“O2’s partnership with Georges St-Pierre, considered one of the greatest mixed martial artists of all time, will allow us to build, test and deliver a category-leading fitness respirator that allows active people to train and compete safely and comfortably,” said Peter Whitby, CEO of O2 Industries. “As environmental stressors like viruses and pollution continue to increase globally, we are committed to building solutions that help people perform their best, no matter what they’re doing.”

O2’s engineering team is designing the mask to provide defence from airborne particles, viruses, dust, mold and bacteria. The fitness mask will be tested by

About 80% of Asymptomatic People With COVID-19 Develop Symptoms

September 29, 2020

| No Comments

| Health Article

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center.

Approximately 20% of asymptomatic people who test positive for COVID-19 will remain symptom-free over time, according to two studies published September 22 in different journals. The researchers propose, therefore, that most asymptomatic patients should be considered presymptomatic.

“Only a minority of people with SARS-CoV-2 have a truly asymptomatic infection. Most patients with SARS-CoV-2 who are asymptomatic at the time of testing will go on to develop symptoms,” study author Nicola Low, MD, head of the Research Group at the Institute of Social and Preventive Medicine at the University of Bern in Switzerland, told Medscape Medical News.

The result also suggests expanded testing for SARS-CoV-2 infection is warranted, especially among those at higher risk, and supports use of control measures including masks, physical distancing, and isolation.

“People with asymptomatic infection are infectious. All should be isolated and

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30